author-photo

Narayan Lebaka

3

Papers

1

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT146: RGX-104, a first-in-class immunotherapy targeting the liver-X receptor (LXR): Initial results from the phase 1b RGX-104 plus docetaxel combination dose escalation cohorts

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)